View Author
hypertension study patient polymorphism progress disease inhibitor effect receptor blood association analysis pressure ace inhibitors response europa value signi population blood pressure pergene bp response system therapy renin odds ratio blood pressure response table body mass index perindopril trial 1.00 ratio signi ficantly agt gene reduction allele bp reduction artery disease haplotype ace-inhibitor therapy angiotensinogen william angiotensin-converting enzyme p values fi ndings enzyme individual determinant lippincott nding wilkin treatment identi fied snps identi result promoter ace inhibitor therapy cerebrovascular disease article ficantly creatinine clearance candidate genes ficant pathway sample reproduction frequency level copyright atp 6a regression analysis signi ficance 0.002 genotype number p value meta-analysi promoter region ace-inhibitor
1 Most Recent Publications
|
A pharmacogenetic analysis of determinants of hypertension and blood pressure response to angiotensin-converting enzyme inhibitor therapy in patients with vascular disease and healthy individuals
(Article)
Brugts, J.J. Isaacs, A. Remme, W.J. Bertrand, M.E. Ninomiya, T. Harrap, S. Chalmers, J. MacMahon, S. Fox, K. Ferrari, R. Simoons, M.L. Danser, A.H.J. Maat, M.P.M. de Boersma, E.R. Duijn, C.M. van Akkerhuis, K.M. Uitterlinden, A.G. Witteman, J.C.M. Cambien, F. Ceconi, C. |
2011-03-01
|